Paricalcitol Reduces Peritoneal Fibrosis in Mice through the Activation of Regulatory T Cells and Reduction in IL-17 Production

Fibrosis is a significant health problem associated with a chronic inflammatory reaction. The precise mechanisms involved in the fibrotic process are still poorly understood. However, given that inflammation is a major causative factor, immunomodulation is a possible therapeutic approach to reduce f...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Mateo, Guadalupe T., Fernández-Míllara, Vanessa, Bellón, Teresa, Liappas, Georgios, Ruiz-Ortega, Marta, López-Cabrera, Manuel, Selgas, Rafael, Aroeira, Luiz S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184804/
https://www.ncbi.nlm.nih.gov/pubmed/25279459
http://dx.doi.org/10.1371/journal.pone.0108477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184804/
https://www.ncbi.nlm.nih.gov/pubmed/25279459
http://dx.doi.org/10.1371/journal.pone.0108477

Ejemplares similares